Skip to content
sellNotable cluster of 7

Thomas R. Kuhn sold $1.0M of ATEX

director, other at Anterix Inc.. 11,654 shares at an average of $87.53, traded Jun 18, 2026, filed Aug 26, 2026.

Warning score
60
Value
$1.0M
11,654 shares
Holdings after
17,731
-60% from before
From 52-week low
+314%
low $17.99, close $74.53
From 52-week high
-10%
high $83.01, as of Jun 18, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $1.0M at market
    +25
  • Share of holdings sold
    Sold 60% of holdings
    +20
  • Cluster
    7 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ATEXOct 13, 2026 · close 84.87
Since filing Aug 26, 2026: -9.9%SPY +1.8% · excess -11.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001571521-26-000002, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 20, 2026AGrant or award
Common Stock
+2,791--19,385Aug 26, 2026
Jun 18, 2026SOpen-market sale
Common Stock
-1,654$79.52$132k17,731Aug 26, 2026
Aug 24, 2026MOption exercise
Common Stock
+10,000$33.62$336k27,731Aug 26, 2026
Aug 24, 2026SOpen-market sale
Common Stock
-4,392$88.18$387k23,339Aug 26, 2026
Aug 24, 2026SOpen-market sale
Common Stock
-4,418$89.12$394k18,921Aug 26, 2026
Aug 24, 2026SOpen-market sale
Common Stock
-790$90.00$71k18,131Aug 26, 2026
Aug 24, 2026SOpen-market sale
Common Stock
-400$91.01$36k17,731Aug 26, 2026
Aug 24, 2026MOption exercise
Stock Option (Right to Buy)derivative
-10,000$0.00$048,998Aug 26, 2026

Related signals

Other insiders at Anterix Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
Pro nowfree Oct 20, 2026
ATEXsell10b5-1
Anterix Inc.
Elena Marquez
Chief Financial Officer
$401k
4,981 shares
-30%
55Moderate
ATEXsell 410b5-1
Anterix Inc.
Scott A. Lang
President and CEO
$1.2M
15,000 shares
-36%
75Notable
ATEXsell 4
Anterix Inc.
Scott A. Lang
President and CEO
$1.2M
15,000 shares
-36%
42Moderate
ATEXsell 4
Anterix Inc.
Leslie B Daniels
director
$210k
2,500 shares
-5%
56Moderate
ATEXsell 4
Anterix Inc.
Heather Martin
Chief Marketing Officer
$679k
8,064 shares
-23%
40Moderate
ATEXsell 5
Anterix Inc.
Gena L Ashe
Chief Legal Officer & Corp Sec
$372k
4,357 shares
-46%
58Moderate
ATEXsell 4
Anterix Inc.
Leslie B Daniels
director
$880k
10,100 shares
-18%
55Moderate
ATEXsell 5
Anterix Inc.
Gena L Ashe
Chief Legal Officer & Corp Sec
$372k
4,357 shares
-46%
50Moderate
ATEXsell 5
Anterix Inc.
Christopher Guttman-McCabe
Chief Reg & Comm Officer
$2.2M
23,439 shares
-34%
55Moderate
ATEXsell 3
Anterix Inc.
William Heard
director
$4.2M
46,400 shares
-3%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Thomas R. Kuhn sold $1.0M of ATEX | InsiderTell